EDGAR Filing Documents for 0001437749-21-008471

Form 8-K - Current report:

SEC Accession No. 0001437749-21-008471

Filing Date

2021-04-07

Accepted

2021-04-07 17:00:28

Documents

Period of Report

2021-04-02

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	cenb20210407_8k.htm	8-K	58122
2	EXHIBIT 10.1	ex_239486.htm	EX-10.1	88975
3	EXHIBIT 10.2	ex_239487.htm	EX-10.2	38406
4	EXHIBIT 10.3	ex_239488.htm	EX-10.3	39875
5	EXHIBIT 10.4	ex_239489.htm	EX-10.4	34493
6	EXHIBIT 10.5	ex_239490.htm	EX-10.5	40202
7	EXHIBIT 10.6	ex_239491.htm	EX-10.6	35608
8	EXHIBIT 10.7	ex_239492.htm	EX-10.7	38785
9	EXHIBIT 10.8	ex_239493.htm	EX-10.8	35467
10	EXHIBIT 10.9	ex_239494.htm	EX-10.9	38668
11	EXHIBIT 10.10	ex_239495.htm	EX-10.10	40172
12	EXHIBIT 10.11	ex_239496.htm	EX-10.11	35565
13	EXHIBIT 10.12	ex_239497.htm	EX-10.12	75360
14	EXHIBIT 10.13	ex_239499.htm	EX-10.13	71966
	Complete submission text file	0001437749-21-008471.txt		672970

Mailing Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9

Business Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9 226-344-0660

CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)